esenteric ischemia is caused by blood flow that is insufficient to meet the metabolic demands of the visceral organs. The severity of ischemia and the type of organ involved depend on the affected vessel and the extent of collateral-vessel blood flow. Despite advances in the techniques used to treat problems in the mesenteric circulation, the most critical factor influencing outcomes in patients with this condition continues to be the speed of diagnosis and intervention. Although mesenteric ischemia is an uncommon cause of abdominal pain, accounting for less than 1 of every 1000 hospital admissions, an inaccurate or delayed diagnosis can result in catastrophic complications; mortality among patients in whom this condition is acute is 60 to 80%. 1-3 This article highlights the pathophysiological features, diagnosis, and treatment of ischemic syndromes in the foregut and intestines. The goal of this review is to improve the understanding and management of this life-threatening disorder. T y pes of Mesenter ic Ischemi a Arterial obstruction, the most common cause of mesenteric ischemia, has both acute and chronic forms. Acute mesenteric ischemia constitutes a surgical emergency. It is associated with embolic occlusion in 40 to 50% of cases (Fig. 1), with thrombotic occlusion of a previously stenotic mesenteric vessel in 20 to 35% of cases, 4 and with dissection or inflammation of the artery in less than 5% of cases. More than 90% of cases of chronic mesenteric ischemia are related to progressive atherosclerotic disease that affects the origins of the visceral vessels; treatment in such cases is focused on elective revascularization to avert the risk of complications and death associated with the development of acute ischemia (Fig. 2). Mesenteric venous thrombosis, which accounts for 5 to 15% of cases of mesenteric ischemia, results in impaired venous outflow, visceral edema, and abdominal pain. Its causes include primary or idiopathic thrombosis; however, 90% of cases are related to thrombophilia, trauma, or local inflammatory changes that may include pancreatitis, diverticulitis, or inflammation or infection in the biliary system. 5 Patients typically have a response to anticoagulation in combination with treatment for the underlying local or systemic processes. Surgical intervention is reserved for patients who are critically ill or whose condition is deteriorating; it is rarely required. The mesenteric circulation is a high-resistance vascular bed in which impaired regional perfusion owing to vasospasm can develop. The resulting ischemia is referred to as nonocclusive mesenteric ischemia. Although the incidence of nonocclusive mesenteric ischemia may be decreasing as awareness of the condition increases and as supportive therapies improve, it accounts for 5 to 15% of all cases of mesenteric ischemia. 6 It is most often associated with cardiac insufficiency